Index/SemaglutideGLP-1 / Metabolic

SEMAGLUTIDE

Ozempic · Wegovy · Rybelsus

FDA-approved GLP-1 agonist — weight loss and blood sugar control.

FDA

Approved

WADA

Not Listed

HALF-LIFE

7 days

ROUTE

SubQ injection (weekly) or oral

SCHEDULE

Once weekly

In Plain English

Semaglutide is the most prescribed peptide in the world. It reduces hunger signals in your brain and slows digestion, making it dramatically easier to eat less. Clinical trials show 15–17% average body weight loss over 68 weeks.

Status & Legality

NATTY?

No Test Exists

No established test exists for this compound.

FDA

Approved

FDA approved for human use.

WADA

Not Listed

Not currently on WADA prohibited list.

COMPOUNDING

Rx Available

Available at licensed pharmacies with prescription.

PRESCRIBED

By prescription

Physicians can prescribe this compound legally.

ROUTE

SubQ injection (weekly) or oral

Administration via subq injection (weekly) or oral.

Who It's For

People with a BMI over 27 with weight-related conditions

Type 2 diabetics managing blood sugar

Anyone who has struggled with appetite control on traditional diets

When Not to Take

Personal or family history of medullary thyroid carcinoma

MEN2 syndrome

History of pancreatitis

Pregnancy

How It Works

Semaglutide is the world's most prescribed therapeutic peptide. A GLP-1 receptor agonist, it reduces appetite by acting on hypothalamic receptors and slows gastric emptying. Approved as Ozempic for T2D and Wegovy for obesity, clinical trials show 15–17% average body weight reduction over 68 weeks.

Side Effects

01

Nausea (very common during titration)

02

Vomiting

03

Diarrhea or constipation

04

Decreased appetite

05

Fatigue

06

Rare: pancreatitis

07

Avoid if personal/family history of thyroid C-cell tumors

Common Mistakes

Skipping the titration phase — causes severe nausea that derails the protocol

Not eating enough protein, leading to significant muscle loss

Stopping abruptly without a tapering plan

Expecting results without any dietary adjustments

Drug & Supplement Interactions

Insulin and diabetes medications — hypoglycemia risk

Oral medications — slowed gastric emptying can affect absorption timing

Warfarin — monitor INR more closely

The PepVault Take

Semaglutide works — the 15–17% weight loss numbers are real. But so are the side effects when you skip titration. The critical mistake is losing muscle mass. High protein intake and resistance training are non-negotiable during any GLP-1 protocol.

Frequently Asked Questions

Stats

ONSET40
DOCUMENTATION95
SIDE INTENSITY55
CYCLE EASE85
POPULARITY98
Add to My Stack

Sources & Studies

1/3
Real human support, no ticket queue.
Stuck on a protocol, billing, or anything else? support@pepvault.co — replies usually inside 24 hours.
Email Support
Research Use OnlyNot Medical AdviceNot FDA Evaluated18+ OnlyWADA Status Tracked

PepVault provides educational and research reference information only. Nothing on this site constitutes medical advice, diagnosis, or treatment. Content has not been evaluated by the U.S. Food and Drug Administration. No compound listed on this site is intended to diagnose, treat, cure, or prevent any disease or medical condition. The legality of peptide compounds varies by jurisdiction — you are solely responsible for compliance with the laws of your country or region. Certain compounds listed are prohibited under the World Anti-Doping Agency (WADA) Prohibited List; athletes subject to anti-doping regulations should independently verify status before use. This site is intended for adults 18 years of age or older. Always consult a licensed healthcare provider before using any compound.

© 2026 PepVault. All rights reserved.